✦ LIBER ✦

A phase I, randomized, open-label study of the multiple-dose pharmacokinetics of vemurafenib in patients withBRAFV600Emutation-positive metastatic melanoma

✍ Scribed by Grippo, J. F.; Zhang, W.; Heinzmann, D.; Yang, K. H.; Wong, J.; Joe, A. K.; Munster, P.; Sarapa, N.; Daud, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Single- and multiple-dose pharmacokineti

✍ Xing Zeng; Yi Feng; Liu Yang; Yu Huang; Dan Zhou; Jing Sun; Yiming Liu; Yuanhui 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 852 KB

Pharmacokinetic properties of isradipine

✍ Wang, Yanran; Jin, Zhaohui; Wang, Zhijun; Jiang, Xuehua; Wang, Ling 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 609 KB

Pharmacokinetic and Safety Profile of Iv

✍ Jiang, Juanjuan; Tian, Lei; Huang, Yiling; Li, Yishi; Xu, Li 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 522 KB

Pharmacokinetics and Tolerability of Van

✍ Li Zhang; Su Li; Yang Zhang; Jing Zhan; Ben-Yan Zou; Robert Smith; Paul D. Marti 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 712 KB

Pharmacokinetic and pharmacodynamic char

✍ Juanjuan Jiang; Lei Tian; Yiling Huang; Yishi Li; Li Xu 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 684 KB

Pharmacokinetics and Pharmacodynamics of

✍ Clarke, Bart L.; Kay Berg, Jolene; Fox, John; Cyran, Jane A.; Lagast, Hjalmar 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 604 KB